|
China Medical System Holdings Limited is a pharmaceutical company focused on the identification, development, and full lifecycle management of differentiated specialty medicines. The company operates through a dual-track model of independent and collaborative research and development, with a core capability in creating markets and brands from scratch. Its therapeutic areas include cardiology, nephrology, metabolism, central nervous system, gastroenterology, ophthalmology, and dermatology. Key products include the TYK2 inhibitor CMS-D001 for systemic lupus erythematosus, the rabies bispecific antibody Jin Su Xi, and the biologic Bai Lu Tuo for atopic dermatitis. The company serves markets in China and emerging regions in Southeast Asia and the Middle East. It also engages in industrial investment, acquiring equity stakes in targets to co-develop products and reinvest returns into research and development. Summarised from the company's own disclosures, fiscal year ended Oct 2026 |
Industry Drug Manufacturers - Specialty & Generic | Homepage cms.net.cn |
| Sector Healthcare | IR page web.cms.net.cn/zh/home | |
|
Tags
specialty pharmaceuticals, cardiology, nephrology, metabolism, central nervous system, gastroenterology, ophthalmology, dermatology, tyk2 inhibitors, bispecific antibodies, biologics, systemic lupus erythematosus, CMS-D001, Jin Su Xi, Bai Lu Tuo
|
Press page web.cms.net.cn/en/news |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 23.21B |
| Market cap (USD) | $ 2.958B |
| P/E | 13.81 |
| PEG | — |
| P/BV | — |
| P/S | 6.73 |
| P/OCF | 26.00 |
| P/FCF | — |
| Dividend yield | 3.6% |
| Turnover / mcap | 0.13% |
| Returns | |
|---|---|
| ROE | — |
| ROI | 508.2% |
| ROIC | 508.2% |
| Profit margin | 18.1% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -23.0% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 6.7% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 CNY | FY 2024 CNY | FY 2023 CNY | FY 2022 CNY | FY 2021 CNY | FY 2020 CNY | FY 2019 CNY | FY 2018 CNY | FY 2017 CNY | FY 2016 CNY | FY 2015 CNY | FY 2014 CNY | FY 2013 USD | FY 2012 USD | FY 2011 USD | FY 2010 USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.212B | 7.469B | 8.013B | 9.15B | 8.337B | 6.946B | 6.074B | 5.433B | 5.349B | 4.901B | 3.553B | 2.945B | 363.256M | 281.866M | 210.393M | 132.177M |
| Net profit | 1.489B | 1.62B | 2.401B | 3.259B | 3.017B | 2.53B | 1.961B | 1.85B | 1.675B | 1.376B | 995.935M | 1.046B | 102.825M | 85.039M | 62.276M | 30.587M |
| Figure | FY 2025 CNY | FY 2024 CNY | FY 2023 CNY | FY 2022 CNY | FY 2021 CNY | FY 2020 CNY | FY 2019 CNY | FY 2018 CNY | FY 2017 CNY | FY 2016 CNY | FY 2015 CNY | FY 2014 CNY | FY 2013 USD | FY 2012 USD | FY 2011 USD | FY 2010 USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 12.35 | 7.45 | 0.74 | 0.07 | 7.14 | 7.67 | 0.15 | 5.96 | 0.38 | — | — | — | — | — | — | — |
| Price performance 12m | 0.7 | 9.14 | 8.76 | -0.99 | 0 | 49.52 | -0.98 | 14.28 | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Announcements made on SGXNet, newest first, routine notices (disclosures of interest, daily buy-backs, listing confirmations, coupons) included. The link opens the announcement on SGX. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding China Medical System Holdings Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| ADIV | 2.27% | 926,000 | $ 1.214M | Jun 30, 2026 |
| RFEM | 0.30% | 155,566 | $ 236.451K | Jul 31, 2026 |
| AVEE | 0.16% | 169,000 | $ 212.831K | Nov 16, 2026 |
| AVEM | 0.06% | 11,754,000 | $ 14.802M | Nov 16, 2026 |
| AVSE | 0.05% | 86,000 | $ 108.304K | Nov 16, 2026 |
| DFSE | 0.05% | 217,000 | $ 285.75K | Nov 12, 2026 |
| DFEV | 0.03% | 521,000 | $ 686.064K | Nov 12, 2026 |
| DFEM | 0.03% | 1,744,000 | $ 2.297M | Nov 12, 2026 |
| DFAE | 0.01% | 967,000 | $ 1.273M | Nov 12, 2026 |
| DFAX | 0.01% | 790,000 | $ 1.04M | Nov 12, 2026 |

